Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now
Close

Hikma Pharmaceuticals PLC (HIK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,074.28 -8.72    -0.42%
23/02 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 681,908
  • Bid/Ask: 1,900.00 / 2,200.00
  • Day's Range: 2,040.00 - 2,091.00
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B0LCW083 
SEDOL:  B0LCW08
Hikma Pharma 2,074.28 -8.72 -0.42%

Hikma Pharmaceuticals PLC Company Profile

 
Get an in-depth profile of Hikma Pharmaceuticals PLC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

8700

Equity Type

ORD

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.

Contact Information

Address 1 New Burlington Place
London, W1S 2HR
United Kingdom
Phone 44 20 7399 2760
Fax 44 20 7399 2761

Top Executives

Name Age Since Title
Mohammed Ali Khaldoun Sati Al-Husry 65 2005 Non-Executive Director
Nabil Rizk - - Chairman of West-ward Pharmaceuticals
Deneen Vojta 57 2022 Independent Non-Executive Director
Mary Regina Henderson 73 2016 Independent Non-Executive Director
John J. Castellani 72 2016 Independent Non-Executive Director
Patrick Noel Butler 63 2014 Non-Independent Non-Executive Director
Cynthia L. Flowers 63 2019 Independent Non-Executive Director
Douglas M. Hurt 67 2020 Independent Non-Executive Director
Victoria M. Hull 61 2022 Senior Independent Non-Executive Director
Laura Balan - 2022 Independent Non-Executive Director
Mazen Samih Taleb Darwazah 66 2005 Executive Vice Chairman & President of MENA
Said Samih Taleb Darwazah 67 2007 Executive Chairman
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HIK Comments

Write your thoughts about Hikma Pharmaceuticals PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email